Exelead Is A Biopharmaceutical Contract Development And Manufacturing Organizationcdmobased In Indianapolisinfounded In 2014The Company Specializes In Complex Injectable Formulationsparticularly Those Utilizing Lipid Nanoparticlelnptechnologywhich Is Essential For Mrna Vaccines And Therapeuticsacquired By Merck Kgaa In 2022Exelead Plays A Significant Role In The Development And Manufacturing Of Critical Pharmaceutical Products The Company Offers A Wide Range Of Services To Support The Pharmaceutical Industryincluding End To End Solutions For Drug Development And Manufacturinglipid Based Formulation Servicesanalytical And Bioanalytical Servicesclinical Trial Supportand Quality Assuranceexelead S Expertise In Lnp Technology Positions It As A Leader In The Mrna Vaccine Spaceand It Has Successfully Delivered Vaccine Batches To Notable Clients Like Pfizer
